[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368096-105":59,"doc-detail-368096-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","racialethnic-disparities-in-time-from-diagnosis-to-surgical-treatment-for-type-i-and-type-ii-endometrial-carcinomas","Racial/ethnic disparities in time from diagnosis to surgical treatment for type I and type II endometrial carcinomas","","Objective. Timeliness of cancer care serves as a quality-of-care indicator, and endometrial cancer type may shape racial/ethnic treatment disparities. This study evaluates racial/ethnic differences in time to surgical treatment for type I versus type II endometrial cancers. Methods. Data from 33,626 women with endometrial cancer in the California Cancer Registry (2000–2019) were analyzed using descriptive statistics, bivariate and stratified multivariable logistic regression models. Results and Conclusions identify treatment-delay patterns by racial/ethnic group, supporting targeted interventions to improve equitable access to timely surgery.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/racialethnic-disparities-in-time-from-diagnosis-to-surgical-treatment-for-type-i-and-type-ii-endometrial-carcinomas/368096/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/racialethnic-disparities-in-time-from-diagnosis-to-surgical-treatment-for-type-i-and-type-ii-endometrial-carcinomas/368096.png","ImageObject",300,407,{"name":92,"@type":93},"MrHarris58","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study evaluate about endometrial cancer care timing?","Question",{"text":112,"@type":113},"It examines racial/ethnic disparities in the time from diagnosis to surgical treatment, comparing type I and type II endometrial cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What dataset and study period were used to analyze treatment delays?",{"text":117,"@type":113},"The study uses data from 33,626 women with endometrial cancer in the California Cancer Registry from 2000 to 2019.",{"name":119,"@type":110,"acceptedAnswer":120},"How were treatment delays and disparities assessed across racial/ethnic groups?",{"text":121,"@type":113},"Treatment delays were evaluated using descriptive statistics, bivariate analyses, and univariate and stratified multivariate logistic regression models by endometrial cancer type.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368096,1790765347,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Author Manuscript Author Manuscript Author Manuscript Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Gynecol Oncol. Author manuscript; available in PMC 2026 May 04. |\n| --- | --- |\n\nPublished in final edited form as:  \nGynecol Oncol. 2025 August ; 199: 139–146. doi:10.1016/j.ygyno.2025.07.002 .  \nRacial/ethnic disparities in time from diagnosis to surgical treatment for type I and type II endometrial carcinomas  \nVictoria E. Rodrigueza,* , Annie Rob, Michael A. Hoytc,d, Sora Park Tanjasirib,d, Robert E. Bristowe, Alana M.W. LeBrónb,d,f  \na Department of Obstetrics & Gynecology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, United States of America  \nb Department of Health, Society, & Behavior, Joe C. Wen School of Population & Public Health, University of California, Irvine, United States of America  \nc Department of Population Health & Disease Prevention, Joe C. Wen School of Population & Public Health, University of California, Irvine, United States of America  \ndChao Family Comprehensive Cancer Center, University of California, Irvine, United States of America  \ne Department of Obstetrics & Gynecology, School of Medicine, University of California, Irvine, United States of America  \nfDepartment of Chicano/Latino Studies, University of California, Irvine, United States of America  \nAbstract  \nObjective. Timeliness of cancer care has been recognized as an indicator of quality of care for numerous cancer sites. Differences in endometrial cancer type may contribute to racial/ethnic disparities in treatment outcomes. This study examines racial/ethnic disparities in time to surgical treatment among type I and type II endometrial cancers.  \nMethods. We used data from 33,626 women with endometrial cancer in the California Cancer Registry between 2000 and 2019. Descriptive statistics, bivariate analyses, univariate logistic regression models, and multivariate logistic regression models stratified by endometrial cancer type (type I or type II) were performed.  \nThis is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n*Corresponding author at: UCLA OB/GYN, Box 951740, 24-137 CHS, Los Angeles, CA 90095-1740, United States of America. [vicrodriguez@mednet.ucla.edu](vicrodriguez@mednet.ucla.edu) (V.E. Rodriguez).  \nCRediT authorship contribution statement  \nVictoria E. Rodriguez: Writing – review & editing, Writing – original draft, Funding acquisition, Formal analysis, Data curation, Conceptualization. Annie Ro: Writing – review & editing, Supervision, Resources, Conceptualization. Michael A. Hoyt: Writing – review & editing, Supervision, Resources, Conceptualization. Sora Park Tanjasiri: Writing – review & editing, Supervision, Resources, Conceptualization. Robert E. Bristow: Writing – review & editing, Supervision, Resources, Conceptualization. Alana  \nM.W. LeBrón: Writing – review & editing, Supervision, Resources, Conceptualization.  \nDeclaration of competing interest  \nThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.  \nAuthor Manuscript Author Manuscript Author Manuscript Author Manuscript  \nRodriguez et al. Page 2  \nResults. Surgical treatment delays were apparent in 35.3 %(n = 22,487) of type I and 34.6 %(n= 11,139) of type II endometrial cancers; treatment delays varied across racial/ethnic group.  \nAmong type I endometrial cancers, multivariable models indicate that American Indian/Alaska Native (odds ratio [OR] 1.47, 95 % CI 1.10–1.97, p \u003C 0.05), Black (OR 1.41, 95 % CI 1.23–1.62, p \u003C 0.001), Hispanic/Latina (OR 1.23, 95 % CI 1.15–1.33, p \u003C 0.001), and Asian or Pacific Islander (OR 1.12, 95 % CI 1.02–1.22, p \u003C 0.01) women had higher odds of experiencing treatment delays compared with White women. Among type II endometrial cancers, multivariable ","cbCaia0X4apXmaPP","https://ap.wps.com/l/cbCaia0X4apXmaPP","pdf",374214,21,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What does the study evaluate about endometrial cancer care timing?\",\"answer\":\"It examines racial/ethnic disparities in the time from diagnosis to surgical treatment, comparing type I and type II endometrial cancers.\"},{\"question\":\"What dataset and study period were used to analyze treatment delays?\",\"answer\":\"The study uses data from 33,626 women with endometrial cancer in the California Cancer Registry from 2000 to 2019.\"},{\"question\":\"How were treatment delays and disparities assessed across racial/ethnic groups?\",\"answer\":\"Treatment delays were evaluated using descriptive statistics, bivariate analyses, and univariate and stratified multivariate logistic regression models by endometrial cancer type.\"}]","Racial/ethnic disparities in time from diagnosis to surgical treatment for type I and type II endometrial carcinomas | PDF",1790174995,53]